Generating evidence for genomic diagnostic test development: workshop summary
Gespeichert in:
| Format: | Elektronisch E-Book |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Washington, D.C.
National Academies Press
©2011
|
| Schlagworte: | |
| Online-Zugang: | FAW01 FAW02 Volltext |
| Beschreibung: | Description based on print version record |
| Beschreibung: | 1 online resource (xx, 85 pages) illustrations |
| ISBN: | 030912204X 0309211042 0309211050 1283213435 9780309122047 9780309211048 9780309211055 9781283213431 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV043037216 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 151120s2011 |||| o||u| ||||||eng d | ||
| 020 | |a 030912204X |9 0-309-12204-X | ||
| 020 | |a 030912204X |9 0-309-12204-X | ||
| 020 | |a 0309211042 |9 0-309-21104-2 | ||
| 020 | |a 0309211050 |c electronic bk. |9 0-309-21105-0 | ||
| 020 | |a 1283213435 |9 1-283-21343-5 | ||
| 020 | |a 9780309122047 |9 978-0-309-12204-7 | ||
| 020 | |a 9780309211048 |9 978-0-309-21104-8 | ||
| 020 | |a 9780309211055 |c electronic bk. |9 978-0-309-21105-5 | ||
| 020 | |a 9781283213431 |9 978-1-283-21343-1 | ||
| 035 | |a (OCoLC)745462026 | ||
| 035 | |a (DE-599)BVBBV043037216 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-1046 |a DE-1047 | ||
| 082 | 0 | |a 576.5 |2 23 | |
| 245 | 1 | 0 | |a Generating evidence for genomic diagnostic test development |b workshop summary |c Theresa Wizemann and Adam C. Berger, rapporteurs ; Roundtable on Translating Genomic-Based Research for Health, Board on Heath Science Policy, Institute of Medicine of the National Academies |
| 264 | 1 | |a Washington, D.C. |b National Academies Press |c ©2011 | |
| 300 | |a 1 online resource (xx, 85 pages) |b illustrations | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a Description based on print version record | ||
| 505 | 8 | |a "Ten years after the sequencing of the human genome, scientists have developed genetic tests that can predict a person's response to certain drugs, estimate the risk of developing Alzheimer's disease, and make other predictions based on known links between genes and diseases. However, genetic tests have yet to become a routine part of medical care, in part because there is not enough evidence to show they help improve patients' health. The Institute of Medicine (IOM) held a workshop to explore how researchers can gather better evidence more efficiently on the clinical utility of genetic tests. Generating Evidence for Genomic Diagnostic Test Development compares the evidence that is required for decisions regarding clearance, use, and reimbursement, to the evidence that is currently generated. The report also addresses innovative and efficient ways to generate high-quality evidence, as well as barriers to generating this evidence. Generating Evidence for Genomic Diagnostic Test Development contains information that will be of great value to regulators and policymakers, payers, health-care providers, researchers, funders, and evidence-based review groups."--Publisher's description | |
| 505 | 8 | 0 | |t Introduction -- |t Stakeholder Perspectives on Evidence -- |t Approaches to Evidence Generation -- |t Overcoming Barriers for Evidence Generation -- |t Considerations Moving Forward -- |t Final Remarks -- |t References -- |t Workshop Agenda -- |t Speaker Biographical Sketches -- |t Registered Attendees |
| 650 | 7 | |a SCIENCE / Life Sciences / Genetics & Genomics |2 bisacsh | |
| 650 | 7 | |a Genetic counseling |2 fast | |
| 650 | 7 | |a Genetic disorders / Diagnosis |2 fast | |
| 650 | 7 | |a Genomics |2 fast | |
| 650 | 7 | |a Human chromosome abnormalities / Diagnosis |2 fast | |
| 650 | 4 | |a Genomics | |
| 650 | 4 | |a Genomics |v Congresses | |
| 650 | 4 | |a Human chromosome abnormalities |x Diagnosis |v Congresses | |
| 650 | 4 | |a Genetic counseling |v Congresses | |
| 650 | 4 | |a Genetic disorders |x Diagnosis |v Congresses | |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |2 gnd-content | |
| 700 | 1 | |a Wizemann, Theresa M. |e Sonstige |4 oth | |
| 700 | 1 | |a Berger, Adam C. |e Sonstige |4 oth | |
| 710 | 2 | |a Institute of Medicine (U.S.) |b Roundtable on Translating Genomic-Based Research for Health |e Sonstige |4 oth | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |a Generating evidence for genomic diagnostic test development |
| 856 | 4 | 0 | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=381797 |x Aggregator |3 Volltext |
| 912 | |a ZDB-4-EBA | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-028461864 | ||
| 966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=381797 |l FAW01 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext | |
| 966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=381797 |l FAW02 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804175398320209920 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV043037216 |
| collection | ZDB-4-EBA |
| contents | "Ten years after the sequencing of the human genome, scientists have developed genetic tests that can predict a person's response to certain drugs, estimate the risk of developing Alzheimer's disease, and make other predictions based on known links between genes and diseases. However, genetic tests have yet to become a routine part of medical care, in part because there is not enough evidence to show they help improve patients' health. The Institute of Medicine (IOM) held a workshop to explore how researchers can gather better evidence more efficiently on the clinical utility of genetic tests. Generating Evidence for Genomic Diagnostic Test Development compares the evidence that is required for decisions regarding clearance, use, and reimbursement, to the evidence that is currently generated. The report also addresses innovative and efficient ways to generate high-quality evidence, as well as barriers to generating this evidence. Generating Evidence for Genomic Diagnostic Test Development contains information that will be of great value to regulators and policymakers, payers, health-care providers, researchers, funders, and evidence-based review groups."--Publisher's description Introduction -- Stakeholder Perspectives on Evidence -- Approaches to Evidence Generation -- Overcoming Barriers for Evidence Generation -- Considerations Moving Forward -- Final Remarks -- References -- Workshop Agenda -- Speaker Biographical Sketches -- Registered Attendees |
| ctrlnum | (OCoLC)745462026 (DE-599)BVBBV043037216 |
| dewey-full | 576.5 |
| dewey-hundreds | 500 - Natural sciences and mathematics |
| dewey-ones | 576 - Genetics and evolution |
| dewey-raw | 576.5 |
| dewey-search | 576.5 |
| dewey-sort | 3576.5 |
| dewey-tens | 570 - Biology |
| discipline | Biologie |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04300nmm a2200613zc 4500</leader><controlfield tag="001">BV043037216</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">151120s2011 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">030912204X</subfield><subfield code="9">0-309-12204-X</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">030912204X</subfield><subfield code="9">0-309-12204-X</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0309211042</subfield><subfield code="9">0-309-21104-2</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0309211050</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">0-309-21105-0</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1283213435</subfield><subfield code="9">1-283-21343-5</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780309122047</subfield><subfield code="9">978-0-309-12204-7</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780309211048</subfield><subfield code="9">978-0-309-21104-8</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780309211055</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">978-0-309-21105-5</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781283213431</subfield><subfield code="9">978-1-283-21343-1</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)745462026</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV043037216</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-1046</subfield><subfield code="a">DE-1047</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">576.5</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Generating evidence for genomic diagnostic test development</subfield><subfield code="b">workshop summary</subfield><subfield code="c">Theresa Wizemann and Adam C. Berger, rapporteurs ; Roundtable on Translating Genomic-Based Research for Health, Board on Heath Science Policy, Institute of Medicine of the National Academies</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Washington, D.C.</subfield><subfield code="b">National Academies Press</subfield><subfield code="c">©2011</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (xx, 85 pages)</subfield><subfield code="b">illustrations</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Description based on print version record</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">"Ten years after the sequencing of the human genome, scientists have developed genetic tests that can predict a person's response to certain drugs, estimate the risk of developing Alzheimer's disease, and make other predictions based on known links between genes and diseases. However, genetic tests have yet to become a routine part of medical care, in part because there is not enough evidence to show they help improve patients' health. The Institute of Medicine (IOM) held a workshop to explore how researchers can gather better evidence more efficiently on the clinical utility of genetic tests. Generating Evidence for Genomic Diagnostic Test Development compares the evidence that is required for decisions regarding clearance, use, and reimbursement, to the evidence that is currently generated. The report also addresses innovative and efficient ways to generate high-quality evidence, as well as barriers to generating this evidence. Generating Evidence for Genomic Diagnostic Test Development contains information that will be of great value to regulators and policymakers, payers, health-care providers, researchers, funders, and evidence-based review groups."--Publisher's description</subfield></datafield><datafield tag="505" ind1="8" ind2="0"><subfield code="t">Introduction --</subfield><subfield code="t">Stakeholder Perspectives on Evidence --</subfield><subfield code="t">Approaches to Evidence Generation --</subfield><subfield code="t">Overcoming Barriers for Evidence Generation --</subfield><subfield code="t">Considerations Moving Forward --</subfield><subfield code="t">Final Remarks --</subfield><subfield code="t">References --</subfield><subfield code="t">Workshop Agenda --</subfield><subfield code="t">Speaker Biographical Sketches --</subfield><subfield code="t">Registered Attendees</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">SCIENCE / Life Sciences / Genetics & Genomics</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Genetic counseling</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Genetic disorders / Diagnosis</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Genomics</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Human chromosome abnormalities / Diagnosis</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Genomics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Genomics</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Human chromosome abnormalities</subfield><subfield code="x">Diagnosis</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Genetic counseling</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Genetic disorders</subfield><subfield code="x">Diagnosis</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wizemann, Theresa M.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Berger, Adam C.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">Institute of Medicine (U.S.)</subfield><subfield code="b">Roundtable on Translating Genomic-Based Research for Health</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="a">Generating evidence for genomic diagnostic test development</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=381797</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-028461864</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=381797</subfield><subfield code="l">FAW01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=381797</subfield><subfield code="l">FAW02</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift gnd-content |
| genre_facet | Konferenzschrift |
| id | DE-604.BV043037216 |
| illustrated | Illustrated |
| indexdate | 2024-07-10T07:15:39Z |
| institution | BVB |
| isbn | 030912204X 0309211042 0309211050 1283213435 9780309122047 9780309211048 9780309211055 9781283213431 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-028461864 |
| oclc_num | 745462026 |
| open_access_boolean | |
| owner | DE-1046 DE-1047 |
| owner_facet | DE-1046 DE-1047 |
| physical | 1 online resource (xx, 85 pages) illustrations |
| psigel | ZDB-4-EBA ZDB-4-EBA FAW_PDA_EBA |
| publishDate | 2011 |
| publishDateSearch | 2011 |
| publishDateSort | 2011 |
| publisher | National Academies Press |
| record_format | marc |
| spelling | Generating evidence for genomic diagnostic test development workshop summary Theresa Wizemann and Adam C. Berger, rapporteurs ; Roundtable on Translating Genomic-Based Research for Health, Board on Heath Science Policy, Institute of Medicine of the National Academies Washington, D.C. National Academies Press ©2011 1 online resource (xx, 85 pages) illustrations txt rdacontent c rdamedia cr rdacarrier Description based on print version record "Ten years after the sequencing of the human genome, scientists have developed genetic tests that can predict a person's response to certain drugs, estimate the risk of developing Alzheimer's disease, and make other predictions based on known links between genes and diseases. However, genetic tests have yet to become a routine part of medical care, in part because there is not enough evidence to show they help improve patients' health. The Institute of Medicine (IOM) held a workshop to explore how researchers can gather better evidence more efficiently on the clinical utility of genetic tests. Generating Evidence for Genomic Diagnostic Test Development compares the evidence that is required for decisions regarding clearance, use, and reimbursement, to the evidence that is currently generated. The report also addresses innovative and efficient ways to generate high-quality evidence, as well as barriers to generating this evidence. Generating Evidence for Genomic Diagnostic Test Development contains information that will be of great value to regulators and policymakers, payers, health-care providers, researchers, funders, and evidence-based review groups."--Publisher's description Introduction -- Stakeholder Perspectives on Evidence -- Approaches to Evidence Generation -- Overcoming Barriers for Evidence Generation -- Considerations Moving Forward -- Final Remarks -- References -- Workshop Agenda -- Speaker Biographical Sketches -- Registered Attendees SCIENCE / Life Sciences / Genetics & Genomics bisacsh Genetic counseling fast Genetic disorders / Diagnosis fast Genomics fast Human chromosome abnormalities / Diagnosis fast Genomics Genomics Congresses Human chromosome abnormalities Diagnosis Congresses Genetic counseling Congresses Genetic disorders Diagnosis Congresses (DE-588)1071861417 Konferenzschrift gnd-content Wizemann, Theresa M. Sonstige oth Berger, Adam C. Sonstige oth Institute of Medicine (U.S.) Roundtable on Translating Genomic-Based Research for Health Sonstige oth Erscheint auch als Druck-Ausgabe Generating evidence for genomic diagnostic test development http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=381797 Aggregator Volltext |
| spellingShingle | Generating evidence for genomic diagnostic test development workshop summary "Ten years after the sequencing of the human genome, scientists have developed genetic tests that can predict a person's response to certain drugs, estimate the risk of developing Alzheimer's disease, and make other predictions based on known links between genes and diseases. However, genetic tests have yet to become a routine part of medical care, in part because there is not enough evidence to show they help improve patients' health. The Institute of Medicine (IOM) held a workshop to explore how researchers can gather better evidence more efficiently on the clinical utility of genetic tests. Generating Evidence for Genomic Diagnostic Test Development compares the evidence that is required for decisions regarding clearance, use, and reimbursement, to the evidence that is currently generated. The report also addresses innovative and efficient ways to generate high-quality evidence, as well as barriers to generating this evidence. Generating Evidence for Genomic Diagnostic Test Development contains information that will be of great value to regulators and policymakers, payers, health-care providers, researchers, funders, and evidence-based review groups."--Publisher's description Introduction -- Stakeholder Perspectives on Evidence -- Approaches to Evidence Generation -- Overcoming Barriers for Evidence Generation -- Considerations Moving Forward -- Final Remarks -- References -- Workshop Agenda -- Speaker Biographical Sketches -- Registered Attendees SCIENCE / Life Sciences / Genetics & Genomics bisacsh Genetic counseling fast Genetic disorders / Diagnosis fast Genomics fast Human chromosome abnormalities / Diagnosis fast Genomics Genomics Congresses Human chromosome abnormalities Diagnosis Congresses Genetic counseling Congresses Genetic disorders Diagnosis Congresses |
| subject_GND | (DE-588)1071861417 |
| title | Generating evidence for genomic diagnostic test development workshop summary |
| title_alt | Introduction -- Stakeholder Perspectives on Evidence -- Approaches to Evidence Generation -- Overcoming Barriers for Evidence Generation -- Considerations Moving Forward -- Final Remarks -- References -- Workshop Agenda -- Speaker Biographical Sketches -- Registered Attendees |
| title_auth | Generating evidence for genomic diagnostic test development workshop summary |
| title_exact_search | Generating evidence for genomic diagnostic test development workshop summary |
| title_full | Generating evidence for genomic diagnostic test development workshop summary Theresa Wizemann and Adam C. Berger, rapporteurs ; Roundtable on Translating Genomic-Based Research for Health, Board on Heath Science Policy, Institute of Medicine of the National Academies |
| title_fullStr | Generating evidence for genomic diagnostic test development workshop summary Theresa Wizemann and Adam C. Berger, rapporteurs ; Roundtable on Translating Genomic-Based Research for Health, Board on Heath Science Policy, Institute of Medicine of the National Academies |
| title_full_unstemmed | Generating evidence for genomic diagnostic test development workshop summary Theresa Wizemann and Adam C. Berger, rapporteurs ; Roundtable on Translating Genomic-Based Research for Health, Board on Heath Science Policy, Institute of Medicine of the National Academies |
| title_short | Generating evidence for genomic diagnostic test development |
| title_sort | generating evidence for genomic diagnostic test development workshop summary |
| title_sub | workshop summary |
| topic | SCIENCE / Life Sciences / Genetics & Genomics bisacsh Genetic counseling fast Genetic disorders / Diagnosis fast Genomics fast Human chromosome abnormalities / Diagnosis fast Genomics Genomics Congresses Human chromosome abnormalities Diagnosis Congresses Genetic counseling Congresses Genetic disorders Diagnosis Congresses |
| topic_facet | SCIENCE / Life Sciences / Genetics & Genomics Genetic counseling Genetic disorders / Diagnosis Genomics Human chromosome abnormalities / Diagnosis Genomics Congresses Human chromosome abnormalities Diagnosis Congresses Genetic counseling Congresses Genetic disorders Diagnosis Congresses Konferenzschrift |
| url | http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=381797 |
| work_keys_str_mv | AT wizemanntheresam generatingevidenceforgenomicdiagnostictestdevelopmentworkshopsummary AT bergeradamc generatingevidenceforgenomicdiagnostictestdevelopmentworkshopsummary AT instituteofmedicineusroundtableontranslatinggenomicbasedresearchforhealth generatingevidenceforgenomicdiagnostictestdevelopmentworkshopsummary |